The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant

This publication has 31 references indexed in Scilit:

• A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
  Nature, 2003
• HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor
  Proceedings of the National Academy of Sciences, 2002
• Prospects for Vaccine Protection Against HIV-1 Infection and AIDS
  Annual Review of Immunology, 2002
• HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor
  AIDS, 1998
• HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator
  Cell, 1995
• The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression
  Clinical and Experimental Immunology, 1995
• HIV-1 nef leads to inhibition or activation of T cells depending on its intracellular localization
  Immunity, 1994
• HIV-1 Matrix Protein p17 Resides in Cell Nuclei in Association with Genomic RNA
  AIDS Research and Human Retroviruses, 1992
• HIV-1 Tat protein trans-activates transcription in vitro
  Cell, 1990
• Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.
  Proceedings of the National Academy of Sciences, 1987